Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "to reduce the development of drug resistant bacteria and maintain the effectiveness of ceftazidime for injection usp and dextrose injection usp and other antibacterial drugs ceftazidime for injection usp and dextrose injection usp should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy ceftazidime for injection and dextrose injection is indicated for the treatment of the following infections when caused by susceptible bacteria ceftazidime for injection usp and dextrose injection usp is a cephalosporin antibacterial indicated in the treatment of the following infections caused by susceptible isolates of the designated microorganisms lower respiratory tract infections 1 1 1 2 1 3 1 4 1 5 1 6 1 7 lower respiratory tract infections including pneumonia caused by pseudomonas aeruginosa pseudomonas haemophilus influenzae klebsiella enterobacter proteus mirabilis escherichia coli serratia citrobacter streptococcus pneumoniae staphylococcus aureus skin and skin structure infections caused by pseudomonas aeruginosa klebsiella escherichia coli proteus proteus mirabilis proteus enterobacter serratia staphylococcus aureus streptococcus pyogenes bacterial septicemia caused by pseudomonas aeruginosa klebsiella haemophilus influenzae escherichia coli serratia streptococcus pneumoniae staphylococcus aureus bone and joint infections caused by pseudomonas aeruginosa klebsiella enterobacter staphylococcus aureus gynecologic infections including endometritis pelvic cellulitis and other infections of the female genital tract caused by escherichia coli intra abdominal infections including peritonitis caused by escherichia coli klebsiella staphylococcus aureus bacteroides bacteroides fragilis central nervous system infections including meningitis caused by haemophilus influenzae neisseria meningitidis pseudomonas aeruginosa streptococcus pneumoniae" ?g. }

• association label "to reduce the development of drug resistant bacteria and maintain the effectiveness of ceftazidime for injection usp and dextrose injection usp and other antibacterial drugs ceftazidime for injection usp and dextrose injection usp should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy ceftazidime for injection and dextrose injection is indicated for the treatment of the following infections when caused by susceptible bacteria ceftazidime for injection usp and dextrose injection usp is a cephalosporin antibacterial indicated in the treatment of the following infections caused by susceptible isolates of the designated microorganisms lower respiratory tract infections 1 1 1 2 1 3 1 4 1 5 1 6 1 7 lower respiratory tract infections including pneumonia caused by pseudomonas aeruginosa pseudomonas haemophilus influenzae klebsiella enterobacter proteus mirabilis escherichia coli serratia citrobacter streptococcus pneumoniae staphylococcus aureus skin and skin structure infections caused by pseudomonas aeruginosa klebsiella escherichia coli proteus proteus mirabilis proteus enterobacter serratia staphylococcus aureus streptococcus pyogenes bacterial septicemia caused by pseudomonas aeruginosa klebsiella haemophilus influenzae escherichia coli serratia streptococcus pneumoniae staphylococcus aureus bone and joint infections caused by pseudomonas aeruginosa klebsiella enterobacter staphylococcus aureus gynecologic infections including endometritis pelvic cellulitis and other infections of the female genital tract caused by escherichia coli intra abdominal infections including peritonitis caused by escherichia coli klebsiella staphylococcus aureus bacteroides bacteroides fragilis central nervous system infections including meningitis caused by haemophilus influenzae neisseria meningitidis pseudomonas aeruginosa streptococcus pneumoniae" assertion.